Quantcast
Channel: » Kristin Okinaka
Viewing all articles
Browse latest Browse all 66

SCCA Clinical Trials

$
0
0

clinical-trialsListed below are clinical trials that have opened at Seattle Cancer Care Alliance in the past several weeks. These trials are looking at new treatments for adult patients with head and neck cancer, gynecologic cancer, lymphoma,  hepatocellular carcinoma, and other gastrointestinal diseases. Check out our website to learn about the more than 200 ongoing clinical trials at SCCA, and follow us on Twitter at @SCCA_Trials for information about recently opened trials.

Chemoradiation Plus Pembrolizumab for Laryngeal Squamous Cell Carcinoma (9649)
A Phase I/ II Study of chemo radiation plus the Anti-PD-1 Antibody, Pembrolizumab (MK-3475) for Locally Advanced Laryngeal Squamous Cell Carcinoma

Pembrolizumab and Carboplatin for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (9740)
Anti-PD-1 Therapy in Combination with Platinum Chemotherapy for Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Dose Escalation Study for CLL, SLL or NHL (20170188)
A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B Cell or T Cell Non-Hodgkin Lymphoma (NHL)

Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib (CELESTIAL)
A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
A Phase III open-label, multicenter trial of maintenance therapy with avelumab (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic, adenocarcinoma of the stomach, or of the gastro-esophageal junction

Combination Treatments for Advanced Gastric Cancer (FRACTION-GC)
A Phase 2, Fast Real-Time Assessment of Combination Therapies in Immuno-Oncology Study in Participants with Advanced Gastric Cancer (FRACTION-Gastric)


Viewing all articles
Browse latest Browse all 66

Latest Images

Trending Articles





Latest Images